From: Molecular dynamics study of enhanced Man5B enzymatic activity
Donor | Acceptor | Prevalence | Donor | Acceptor | Prevalence |
---|---|---|---|---|---|
BGLC (-1) | HIS205-S | 48.55% | TRP291-S | BMAN (1) | 85.10% |
TRP291-S | BGLC (1) | 48.50% | BMAN (-1) | HIS205-S | 78.34% |
HIS205-S | BGLC (-1) | 32.46% | TRP210-S | BMAN (-1) | 71.92% |
GLU137-S | BGLC (-1) | 28.84% | TYR198-S | BMAN (-1) | 44.41% |
GLU137-S | BGLC (-2) | 23.13% | GLU137-S | BMAN (-2) | 43.60% |
BGLC (-3) | GLY177-B | 21.70% | GLN199-S | BMAN (-3) | 25.46% |
GLN199-S | BGLC (-3) | 20.99% | ASN292-S | BMAN (1) | 24.08% |
BGLC (-1) | TYR198-S | 18.85% | ASN140-S | BMAN (-3) | 16.99% |
ASN92-S | BGLC (1) | 15.14% | ASN92-S | BMAN (-1) | 16.61% |
TRP210-S | BGLC (-1) | 14.61% | BMAN (-3) | GLY177-B | 16.99% |
ASN180-S | BGLC (-3) | 11.90% | BMAN (-2) | GLU137-S | 14.80% |
ASN180-S | BMAN (-3) | 14.71% | |||
GLU137-S | BMAN (-1) | 9.85% |